Sign Out
General precautions: Since there is the possibility that serious adverse effect such as shock etc. may occur when the patient inject at interval or continuous administration, it should be given with caution to patients and the patients should be observed carefully.
Take a notice that the treatment of ITP with this drug is not causal therapy but symptomatic therapy.
In most of case, ITP of children remitted spontaneously.
Since it is difficult to delete or inactivate completely human parvovirus B19 etc. in the current manufacturing process of plasma fraction preparation, there is the possibility of infection. Therefore, the patients should be observed carefully after administration.
Do not administer this drug mixed with other solution except the solution which is near neutral pH such as saline, electrolyte solution containing sorbitol.
Intravenous instillation method is desirable. When administered intravenously by injection, administer very slowly. (Special attention should be needed for patient with agammaglobulinemia, hypogamma-globulinemia).
Do not use if any precipitation is shown.
Use immediately within one hour after opening, If once opened, the residue remainders should not be used since this drug does not contain any preservatives.
